beta-solamarine has been researched along with Carcinoma, Epidermoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, A; Li, X; Lou, H; Sun, L; Yuan, H; Zhao, Y | 1 |
| Cham, BE; Daunter, B; Evans, RA | 1 |
1 trial(s) available for beta-solamarine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Topical treatment of malignant and premalignant skin lesions by very low concentrations of a standard mixture (BEC) of solasodine glycosides.
Topics: Administration, Topical; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Glycosides; Humans; Keratosis; Pharmaceutical Vehicles; Phytosterols; Precancerous Conditions; Skin Neoplasms; Solanaceous Alkaloids | 1991 |
1 other study(ies) available for beta-solamarine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Solamargine, a steroidal alkaloid glycoside, induces oncosis in human K562 leukemia and squamous cell carcinoma KB cells.
Topics: Antineoplastic Agents, Phytogenic; Blister; Blotting, Western; Carcinoma, Squamous Cell; Cell Membrane; Cytoskeleton; Fluorescent Antibody Technique; Gene Expression; Humans; K562 Cells; KB Cells; L-Lactate Dehydrogenase; Leukemia, Erythroblastic, Acute; Multidrug Resistance-Associated Proteins; Solanaceous Alkaloids; Time Factors | 2011 |